Given today's Pfizer/BioNTech paper, I would expect that we'll see similar publications shortly on their other 3 mRNA candidates. One other modified-nucleoside (like today's), one extra-uridine, and one self-amplifying. Should make for very interesting comparisons. $PFE $BNTX